PharmaCyte Biotech, Inc. (PMCB) Q2 2025 Earnings

Screener

Reported August 11, 2025 · Before market open

EPS$1.73

Next report

Dec 16, 2026 (in a month)

EPS estimate-$0.06

Versus estimates

Diluted EPS

Q3 2026-$0.54Miss by $0.48 Q2 2026-$0.54Miss by $0.48 Q1 2026$0.13Beat by $0.19 Q4 2025-$0.32 Q3 2025-$0.09

Q2 2025$1.73

FAQ

When did PharmaCyte Biotech, Inc. report Q2 2025 earnings?: PharmaCyte Biotech, Inc. (PMCB) reported Q2 2025 earnings on August 11, 2025 before market open.
What were PharmaCyte Biotech, Inc.'s Q2 2025 revenue and EPS?: PharmaCyte Biotech, Inc. reported eps of $1.73 for Q2 2025.

Ask the moment PharmaCyte Biotech, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk